This site is intended for healthcare professionals only

Diabetes &
Primary Care


Share this article

How to initiate and support continuous glucose monitoring

Nicola Milne
Publisher’s note: This article is now out of date. A revised version can be found here.

Publisher’s note: This article is now out of date. A revised version can be found here.


1. Wilmot EG, Evans M, Barnard-Kelly K et al (2021) Flash glucose monitoring with the FreeStyle Libre 2 compared with self-monitoring of blood glucose in suboptimally controlled type 1 diabetes: the FLASH-UK randomised controlled trial protocol. BMJ Open 11: e050713

2. Lind M, Polonsky W, Hirsch IB et al (2017) Continuous glucose monitoring vs conventional therapy for glycemic control in adults with type 1 diabetes treated with multiple daily insulin injections: the GOLD randomized clinical trial. JAMA 317: 379–87

3. DSN Forum UK (2022) Intermittent and real-time continuous glucose monitoring systems comparison chart. Available at: (accessed 26.09.22)

4. DVLA (2019) A guide to insulin treated diabetes and driving [INF294]. DVLA, Swansea. Available at: (accessed 30.08.22)

5. Alkhatatbeh MJ, Abdalqader NA, Alqudah MAY (2019) Impaired awareness of hypoglycaemia in insulin-treated type 2 diabetes mellitus. Curr Diabetes Rev 15: 407–13

6. Alva S, Bailey T, Brazg R et al (2022) Accuracy of a 14-day factory-calibrated continuous glucose monitoring system with advanced algorithm in pediatric and adult population with diabetes. J Diabetes Sci Technol 16: 70–7

7. Shah VN, DuBose SN, Li Z et al (2019) Continuous glucose monitoring profiles in healthy nondiabetic participants: a multicenter prospective study. J Clin Endocrinol Metab 104: 4356–64

8. Battelino T, Danne T, Bergenstal RM et al (2019) Clinical targets for continuous glucose monitoring data interpretation: recommendations from the International Consensus on Time in Range. Diabetes Care 42: 1593–603

9. Beck RW, Riddlesworth TD, Ruedy K et al; DIAMOND Study Group (2017) Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: a randomized trial. Ann Intern Med 167: 365–74

Related content
Editorial: Updated guidance on prescribing incretin-based therapy, cardiovascular risk reduction and the wider uptake of CGM
Free for all UK & Ireland healthcare professionals

Sign up to all DiabetesontheNet journals


By clicking ‘Subscribe’, you are agreeing that are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our Privacy Policy.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.